Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD
SHZ: 300534.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Zhengcai Zhao
- Employees
- 634
- Headquarters
- Lanzhou, China
- IPO year
- 2016
- Market cap
- CN¥2.8B
- Website
- https://www.lsrfzy.com
Loading 300534…
Loading profile data…Frequently asked questions about 300534
What does Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534.SZ) do?
Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd researches, develops, produces, and sells Chinese medicines, health food, and APIs. It offers Yuanhu Analgesic dropping pills, Qiwei Wenyang capsules, Maxing cough capsules, Shuxinning tablets, Panax notoginseng pills, Anti-inflammatory and gallbladder tablets, Children's Qingfei cough tablets...
Where does 300534.SZ trade?
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300534.SZ in?
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD?
Zhengcai Zhao is the chief executive officer of Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534.SZ).
Where is Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD headquartered?
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD is headquartered in China.
Does 300534.SZ pay a dividend?
Yes — Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534.SZ) paid a trailing twelve-month dividend of CNY 0.04 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300534.SZ go public?
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534.SZ) completed its initial public offering in 2016.